Professor Paul Knoepfler, Ph.D.

Paul Knoepfler, Ph.D. is a Professor at UC Davis School of Medicine in Cell Biology and Human Anatomy. His lab does research on stem cells and cancer, especially from an epigenomic angle. He also has been working on policy and ethics matters for many years. The author of 3 books, he also has a popular TED talk on designer babies.

Fact-checking stem cell therapy for autism: still a risky idea

Duke-Curemark-autism-study-pamphlet

The other day I gave a talk in part about stem cell hype and mentioned as an example how the idea of already doing stem cell therapy for autism seems so misguided to me now.  On the whole, in my view there are major downsides and risks for autistic kids whose parents are already having …

Fact-checking stem cell therapy for autism: still a risky idea Read More »

Weekly reads: CRISPR’d marsupial, outpatient recovery post stem cell transplants, Parkinson’s, pubs

CRISPR'd baby opossums.

This edition of The Niche weekly reads has a bit more good news than usual including on stem cell transplants. It’s nice to see positive developments like some recipients of hematopoietic stem cell transplants being able to stay at home afterwards. Also, a reminder. You have until July 31 to enter our stem cell video …

Weekly reads: CRISPR’d marsupial, outpatient recovery post stem cell transplants, Parkinson’s, pubs Read More »

Translating the FDA’s Q&A on end of stem cell grace period

The Rosetta Stone, The FDA

The FDA grace period for stem cell clinics and others using regenerative medicine products like stem cells is over. It appears the agency is serious about enforcement moving forward. They have released several statements about the end of what they call the “enforcement discretion” period, which just means in English a grace period for marketers …

Translating the FDA’s Q&A on end of stem cell grace period Read More »

Stem cell therapy: the good, the bad, & the muddy waters

stem-sells-marketing

How can you tell who to trust in the world of stem cell therapy? What information can a patient trust? Once upon a time about a dozen years ago it seemed a much simpler question. There were universities and biotech companies doing legit research as well as clinical trials, and there were physicians doing bone …

Stem cell therapy: the good, the bad, & the muddy waters Read More »

Weekly reads: stem cells to gametes, no PRP benefit, WHO CRISPR, pubs

making human eggs from stem cells

The paper of the week is from Science on making ovarian follicles and actual eggs from stem cells. It’s just in mice, but this line of work tends to stir people up. We’ll dive into that in a moment. But first some good news. We’re up to 146 subscribers on our stem cell YouTube channel …

Weekly reads: stem cells to gametes, no PRP benefit, WHO CRISPR, pubs Read More »

Enter The Niche stem cell videos contest with $100 prize

stem cell videos, YouTube Channel

Who doesn’t like stem cell videos? Some of you already know that we have a stem cell YouTube channel with me, Paul Knoepfler, talking about many important topics on stem cells. The point of the channel is science-based educational outreach to people all over the world. With this in mind, I’ve been thinking it’d be …

Enter The Niche stem cell videos contest with $100 prize Read More »

Weekly reads: stem cells vs. viruses, prostate cancer, apoptotic cell niche function, more

Morinaga et al Nature 2021 Stem cells and hair loss

The paper of the week is An isoform of Dicer protects mammalian stem cells against multiple RNA viruses published in Science. The take-home from the abstract is that the data, “demonstrate that mammalian stem cells can protect themselves from some RNA viruses by expressing an alternatively spliced isoform of the enzyme Dicer called aviD, which potentiates …

Weekly reads: stem cells vs. viruses, prostate cancer, apoptotic cell niche function, more Read More »

FDA alleges Cell Surgical Network links to US Stem Cell & COVID plan

Sean Berman Cell Surgical Network, ACT

The FDA has sought injunctions in federal court against two stem cell clinic firms including the clinic chain Cell Surgical Network headquartered here in California and US Stem Cell in Florida. According to new documents filed by the government in federal court here in California there may be more ties between the clinic firms than …

FDA alleges Cell Surgical Network links to US Stem Cell & COVID plan Read More »

Weekly reads: life extension & BioViva, clinics & anti-vax, axolotls, systemic CRISPR

BioViva CEO Liz Parrish in YouTube video.

Let’s start off today’s recommended reads with the topic of life extension. No controversy there, right? This comes to mind because of a new preprint from BioViva, Liz Parrish, and George Church. I’m hoping to cover this on our Stem Cell Channel on YouTube.  Gene therapy and life extension research The preprint is entitled, “New …

Weekly reads: life extension & BioViva, clinics & anti-vax, axolotls, systemic CRISPR Read More »